21‐Hydroxylase Deficient Congenital Adrenal Hyperplasia Due to Maternal Uniparental Isodisomy
Open Access
- 1 January 2026
- journal article
- case report
- Published by Wiley in Case Reports in Endocrinology
- Vol. 2026 (1) , 3596318
Abstract
Congenital adrenal hyperplasia (CAH) due to 21‐hydroxylase deficiency (21‐OHD CAH) is an autosomal recessive genetic condition that results from pathogenic variants in the CYP21A2 gene. Noncarrier parents are found in a small percentage of cases, typically due to de novo variants. However, uniparental disomy (UPD) should also be considered. UPD is generally suspected when an individual with an autosomal recessive condition is found to be homozygous for a rare pathogenic variant and consanguinity has been ruled out. However, UPD in CYP21A2 may be hard to recognize because homozygous genotypes are not uncommon. We present the case of a 19‐month‐old male born preterm who presented to pediatric endocrinology after a positive newborn screen for CAH. He was small for gestational age, with a history of adrenal crisis and elevated 17‐hydroxyprogesterone (17‐OHP). Genetic testing revealed homozygosity for two common pathogenic CYP21A2 variants: c.293‐13C >G and c.1360C >T (p.Pro454Ser), both variants were found in the heterozygous state in the mother while the father’s CYP21A2 molecular testing was negative. UPD testing was pursued and the results were consistent with the patient having maternal isodisomy of chromosome 6. In cases of patients with CAH due to homozygous CYP21A2 variants, suspicion for UPD may be increased if the child also presents with intrauterine growth restriction (IUGR), or transient neonatal diabetes (TNDM) mellitus, associated with maternal and paternal UPD of chromosome 6, respectively.Keywords
This publication has 13 references indexed in Scilit:
- Maternal uniparental disomy for chromosome 6 in 2 prenatal cases with IUGR: case report and literature reviewMolecular Cytogenetics, 2024
- A genomic mutational constraint map using variation in 76,156 human genomesNature, 2023
- Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and ManagementEndocrine Reviews, 2021
- The maternal uniparental disomy of chromosome 6 (upd(6)mat) “phenotype”: result of placental trisomy 6 mosaicism?Molecular Genetics & Genomic Medicine, 2017
- Genotype–phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiencyProceedings of the National Academy of Sciences of the United States of America, 2013
- Comprehensive Genetic Analysis of 182 Unrelated Families with Congenital Adrenal Hyperplasia due to 21-Hydroxylase DeficiencyThe Journal of Clinical Endocrinology & Metabolism, 2011
- Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice GuidelineThe Journal of Clinical Endocrinology & Metabolism, 2010
- Maternal 21‐hydroxylase deficiency and uniparental isodisomy of chromosome 6 and X results in a child with 21‐hydroxylase deficiency and Klinefelter syndromeAmerican Journal of Medical Genetics Part A, 2006
- Intrauterine Growth Retardation Associated with Maternal Uniparental Disomy for Chromosome 6 Unmasked by Congenital Adrenal HyperplasiaPediatric Research, 1999
- Uniparental disomy for chromosome 6 results in steroid 21-hydroxylase deficiency: evidence of different genetic mechanisms involved in the production of the disease.Journal of Medical Genetics, 1998